{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:02:10Z","timestamp":1749355330168,"version":"3.41.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,7]]},"DOI":"10.7759\/cureus.85499","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T09:25:26Z","timestamp":1749288326000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Focal Segmental Glomerulosclerosis Presenting With Acute Kidney Injury and Nephrotic Syndrome: A Case Report With Sustained Remission"],"prefix":"10.7759","author":[{"given":"Gautam","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Sonavane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Shirsat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati VD","year":"2011","unstructured":"D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011, 365:2398-411. 10.1056\/NEJMra1106556","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.07.008","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States","volume":"44","author":"Kitiyakara C","year":"2004","unstructured":"Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004, 44:815-25. 10.1053\/j.ajkd.2004.07.008","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00427","article-title":"Therapeutic trials in adult FSGS: Lessons learned and the road forward","volume":"17","author":"De Vriese AS","year":"2021","unstructured":"De Vriese AS, Wetzels JF, Glassock RJ, Sethi S, Fervenza FC. Therapeutic trials in adult FSGS: Lessons learned and the road forward. Nat Rev Nephrol. 2021, 17:619-30. 10.1038\/s41581-021-00427","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg AZ","year":"2017","unstructured":"Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017, 12:507-17. 10.2215\/CJN.05960616","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000481634","article-title":"Protecting podocytes: A key target for therapy of focal segmental glomerulosclerosis","volume":"47","author":"Campbell KN","year":"2018","unstructured":"Campbell KN, Tumlin JA. Protecting podocytes: A key target for therapy of focal segmental glomerulosclerosis. Am J Nephrol. 2018, 47:14-29. 10.1159\/000481634","journal-title":"Am J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13463","article-title":"Advanced therapeutics in focal and segmental glomerulosclerosis","volume":"23","author":"Liu Y","year":"2018","unstructured":"Liu Y, Shi Y, Ren R, Xie J, Wang W, Chen N. Advanced therapeutics in focal and segmental glomerulosclerosis. Nephrology (Carlton). 2018, 23:57-61. 10.1111\/nep.13463","journal-title":"Nephrology (Carlton)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021, 100:S1-S276. 10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308550","article-title":"Sparsentan versus irbesartan in focal segmental glomerulosclerosis","volume":"389","author":"Rheault MN","year":"2023","unstructured":"Rheault MN, Alpers CE, Barratt J, et al.. Sparsentan versus irbesartan in focal segmental glomerulosclerosis. N Engl J Med. 2023, 389:2436-45. 10.1056\/NEJMoa2308550","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371475-primary-focal-segmental-glomerulosclerosis-presenting-with-acute-kidney-injury-and-nephrotic-syndrome-a-case-report-with-sustained-remission","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T09:25:26Z","timestamp":1749288326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371475-primary-focal-segmental-glomerulosclerosis-presenting-with-acute-kidney-injury-and-nephrotic-syndrome-a-case-report-with-sustained-remission"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.85499","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,7]]}}}